EUVIMEDEUVIMED entdecken
Crossref

Investigation of an Mpox Outbreak Affecting Many Vaccinated Persons in Chicago, Illinois—March 2023–June 2023

Emily A G Faherty iD, Taylor Holly, Yasmin P Ogale, Hillary Spencer, Ashley M Becht, Gordon Crisler, Michael Wasz, Patrick Stonehouse, Hannah J Barbian, Christy Zelinski, Alyse Kittner, Dorothy Foulkes und 20 weitere

Clinical Infectious Diseases · 19.07.2024 · 79 (1) · 122-129

DOI: 10.1093/cid/ciae181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 03.04.2024. Verfasst von Emily A G Faherty und 31 weiteren Autor:innen. Beteiligte Einrichtung: Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Disease Outbreaks, Vaccination, Mpox, Monkeypox. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: US government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

After months of few mpox cases, an increase in cases was reported in Chicago during May 2023, predominantly among fully vaccinated (FV) patients. We investigated the outbreak scope, differences between vaccinated and unvaccinated patients, and hypotheses for monkeypox virus (MPXV) infection after vaccination.

Methods

We interviewed patients and reviewed medical records to assess demographic, behavioral, and clinical characteristics; mpox vaccine status; and vaccine administration routes. We evaluated serum antibody levels after infection and compared patient viral genomes with MPXV sequences in available databases. We discussed potential vaccine compromise with partners who manufactured, handled, and administered the vaccine associated with breakthrough infections.

Results

During 18 March–27 June 2023, we identified 49 mpox cases; 57% of these mpox patients were FV. FV patients received both JYNNEOS doses subcutaneously (57%), intradermally (7%), or via heterologous administration (36%). FV patients had more median sex partners (3; interquartile range [IQR] = 1–4) versus not fully vaccinated patients (1; IQR = 1–2). Thirty-six of 37 sequenced specimens belonged to lineage B.1.20 of clade IIb MPXV, which did not demonstrate any amino acid changes relative to B.1, the predominant lineage from May 2022. Vaccinated patients demonstrated expected humoral antibody responses; none were hospitalized. No vaccine storage excursions were identified. Approximately 63% of people at risk for mpox in Chicago were FV during this period.

Conclusions

Our investigation indicated that cases were likely due to frequent behaviors associated with mpox transmission, even with relatively high vaccine effectiveness and vaccine coverage. Cases after vaccination might occur in similar populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease OutbreaksVaccinationMpox, MonkeypoxHumansChicagoFemaleMaleAdultMiddle AgedYoung AdultAntibodies, ViralAgedAdolescentViral VaccinesGenome, Viral

Stichwörter der Autor:innen

monkeypox virusmpoxoutbreakvaccination

Substanzen

Antibodies, ViralViral Vaccines

Autor:innen und Institutionen

  • Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Chicago Department of Public Health, Chicago, Illinois, USA.
  • Departments of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA.
  • National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Office of the Chief Operating Officer, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

ORCID-Profile: Emily A G Faherty, Massimo Pacilli, Agam K Rao

Förderung

  • US government

Zitieren

APA

Faherty, E. A. G., Holly, T., Ogale, Y. P., Spencer, H., Becht, A. M., Crisler, G., Wasz, M., Stonehouse, P., Barbian, H. J., Zelinski, C., Kittner, A., Foulkes, D., Anderson, K. W., Evans, T., Nicolae, L., Staton, A., Hardnett, C., Townsend, M. B., Carson, W. C., …, & Tabidze, I. (2024). Investigation of an Mpox Outbreak Affecting Many Vaccinated Persons in Chicago, Illinois—March 2023–June 2023. Clinical Infectious Diseases, 79(1), 122-129. https://doi.org/10.1093/cid/ciae181

Vancouver

Faherty EAG, Holly T, Ogale YP, Spencer H, Becht AM, Crisler G, et al. Investigation of an Mpox Outbreak Affecting Many Vaccinated Persons in Chicago, Illinois—March 2023–June 2023. Clinical Infectious Diseases. 2024;79(1):122-129. doi:10.1093/cid/ciae181

BibTeX
@article{Faherty2024,
  author = {Faherty, Emily A G and Holly, Taylor and Ogale, Yasmin P and Spencer, Hillary and Becht, Ashley M and Crisler, Gordon and Wasz, Michael and Stonehouse, Patrick and Barbian, Hannah J and Zelinski, Christy and Kittner, Alyse and Foulkes, Dorothy and Anderson, Kendall W and Evans, Tiffany and Nicolae, Lavinia and Staton, Amber and Hardnett, Carla and Townsend, Michael B and Carson, William C and Satheshkumar, Panayampalli S and Hutson, Christina L and Gigante, Crystal M and Quilter, Laura A S and Gorman, Susan and Borah, Brian and Black, Stephanie R and Pacilli, Massimo and Kern, David and Kerins, Janna and McCollum, Andrea M and Rao, Agam K and Tabidze, Irina},
  title = {Investigation of an Mpox Outbreak Affecting Many Vaccinated Persons in Chicago, Illinois—March 2023–June 2023},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {79},
  number = {1},
  pages = {122--129},
  doi = {10.1093/cid/ciae181}
}
Kostenlos starten →